1. Home
  2. SNPS vs BSX Comparison

SNPS vs BSX Comparison

Compare SNPS & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Synopsys Inc.

SNPS

Synopsys Inc.

HOLD

Current Price

$392.65

Market Cap

79.0B

Sector

Technology

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$61.39

Market Cap

93.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNPS
BSX
Founded
1986
1979
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.0B
93.4B
IPO Year
1994
2010

Fundamental Metrics

Financial Performance
Metric
SNPS
BSX
Price
$392.65
$61.39
Analyst Decision
Buy
Strong Buy
Analyst Count
14
21
Target Price
$540.71
$103.38
AVG Volume (30 Days)
1.4M
14.3M
Earning Date
05-27-2026
04-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
55.20
EPS
0.34
1.94
Revenue
$5,081,542,000.00
$9,076,000,000.00
Revenue This Year
$39.19
$11.91
Revenue Next Year
$10.73
$10.26
P/E Ratio
$1,189.62
$31.60
Revenue Growth
20.87
12.49
52 Week Low
$376.18
$60.59
52 Week High
$651.65
$109.50

Technical Indicators

Market Signals
Indicator
SNPS
BSX
Relative Strength Index (RSI) 40.16 29.13
Support Level $377.84 N/A
Resistance Level $447.88 $76.77
Average True Range (ATR) 13.90 1.76
MACD 0.74 -0.13
Stochastic Oscillator 20.43 10.23

Price Performance

Historical Comparison
SNPS
BSX

About SNPS Synopsys Inc.

Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: